ALLERGEN IMMUNOTHERAPY

Clinical trials for ALLERGEN IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new ALLERGEN IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for ALLERGEN IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can an RNA shot teach the immune system to ignore cedar pollen?

Symptom relief Recruiting now

This early-stage trial tests an experimental RNA immunotherapy called ITI-9001 in adults with Japanese cedar pollen allergy. The treatment aims to retrain the immune system to reduce allergic reactions. Researchers are primarily checking safety and how well people tolerate the sh…

Matched conditions: ALLERGEN IMMUNOTHERAPY

Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Symptom relief

Last updated Jul 26, 2026 00:00 UTC

ALLERGEN IMMUNOTHERAPY

Get alerted when new ALLERGEN IMMUNOTHERAPY trials appear

Can an RNA shot teach the immune system to ignore cedar pollen?